Effect of sodium stibogluconate on hepatic mixed function oxidase system and marker enzymes of golden hamsters during Leishmania donovani infection

Indian Journal of Experimental Biology

Volumn 35, Issue 4, 1997, Pages 393-396

  Mittal, N ^a   Gupta, N ^a   Goyal, N ^a   Singh, A K ^a   Guru, P Y ^a   Pandey, V C ^a   Rastogi, A K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOCHROME P450; GLUCOSE 6 PHOSPHATASE; OXIDOREDUCTASE; RIBONUCLEASE II; STIBOGLUCONATE SODIUM; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ANALYSIS; HAMSTER; INFECTION RISK; LEISHMANIA DONOVANI; LIVER INJURY; MALE; MORTALITY; NONHUMAN;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CRICETINAE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; MALE; MESOCRICETUS; MIXED FUNCTION OXYGENASES;

ANIMALIA; CRICETINAE; LEISHMANIA DONOVANI; MESOCRICETUS AURATUS;

EID: 0031408472     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reed S G, in Immunology of leishmania infections in parasitic diseases, Vol. 1. edited by Mansfield J M, (Marcel Dekker, New York) (1981) 291.
2. Stauber L A, Ann N Y Acad Sci, 113 (1963) 409.
3. Singh A K, Guru P Y, Sharma S K, Rastogi A K & Garg N K, Med Sci Res, 17 (1989) 787.
4. Singh A K, Tekwani B L, Guru P Y, Rastogi A K & Pandey V C, Pharmacol Res, 21 (1989) 507.
5. Singh A K, Srivastava A K, Gupta S C, Guru P Y, Rastogi A K & Garg N K, Indian J Parasitol, 14 (1990) 83.
6. Berman J D, Rev Inf Dis, 10 (1988) 560.
7. Davidson R N & Croft S L, Trans Roy Soc Trop Med Hyg, 87 (1993) 130.
8. Bhatnagar S, Guru P Y, Katiyar J C, Srivastava R, Mukherjee A, Akhtar M S, Seth M & Bhadhuri A P, Indian J Med Res, 89 (1989) 439.
9. Wright P J, Leathwood P D & Plummer D T, Enzymologia, 42 (1972) 459.
10. DeDuve C, Pressman B C, Gianetto R, Wattiaux R & Applemans F, Biochem J, 60 (1991) 604.
11. Slater E C & Bonner W D, Biochem J, 52 (1952) 185
12. Reitman M D & Frankel S, Am Clin Pathol, 28 (1957) 56.
13. Hubscher G & West G R, Nature, 205 (1965) 799.
14. Mazell P, in Fundamentals of drug metabolism and drug disposition edited by La Du B N, Mandai H G, Way E L (Williams and Wilkin Baltimore) (1971) 546.
15. Brodie B B & Axelrod J, J Pharmacol Exp Ther, 94 (1948) 22.
16. Lowry O H, Rosenbrough N J, Farr A L & Randall R J, J Biol Chem, 193 (1951) 265.
17. Gutierrez Y, Maksem J A & Reiner N E, Am J Pathol, 114 (1984) 222.
18. McElarth M J, Murray H W & Cohn Z A, J Exp Med, 167 (1988) 1927.
19. Hervas J A, Albert P, Ferragut J & Canet R, Ped Infec Dis J, 10 (1991) 409.
20. Brayceson A, in The Leishmaniasis in biology and medicine, edited by Peters, W & Killick-Kendrick R (Academic Press, USA) (1987) 848.
21. Berman J D, Ksionski G, Chapman W L, Waits V B & Hanson W L, Antimicrob Agents Chemother, 36 (1992) 1978.
22. Thakur C P, Kumar M & Pandey A K, Am J Trop Med Hyg, 45 (1991) 435.
23. Martinez S & Marr J J, New Eng J Med, 326 (1992) 741.